Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
1.880
+0.030 (1.62%)
Mar 6, 2026, 4:00 PM EST - Market closed
CELZ Employees
Creative Medical Technology Holdings had 4 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
4
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,500
Profits / Employee
-$1,490,352
Market Cap
6.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4 | 0 | - |
| Dec 31, 2023 | 4 | 0 | - |
| Dec 31, 2022 | 4 | 0 | - |
| Dec 31, 2021 | 4 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aptevo Therapeutics | 37 |
| Theriva Biologics | 22 |
| Processa Pharmaceuticals | 10 |
| XTL Biopharmaceuticals | 10 |
| Aprea Therapeutics | 8 |
| Immuron | 7 |
| Can-Fite BioPharma | 5 |
| Addex Therapeutics | 2 |
CELZ News
- 7 weeks ago - Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain - GlobeNewsWire
- 2 months ago - Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative - GlobeNewsWire
- 2 months ago - Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point - GlobeNewsWire
- 3 months ago - Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201 - GlobeNewsWire
- 4 months ago - Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits - GlobeNewsWire
- 4 months ago - Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds - GlobeNewsWire
- 4 months ago - Creative Medical Technology Holdings Issues Letter to Shareholders - GlobeNewsWire
- 5 months ago - Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs - GlobeNewsWire